2021
DOI: 10.1021/acs.biomac.1c01137
|View full text |Cite
|
Sign up to set email alerts
|

Dynamic Glycopeptide Dendrimers: Synthesis and Their Controllable Self-Assembly into Varied Glyco-Nanostructures for the Biomimicry of Glycans

Abstract: A library of 14 dynamic glycopeptide amphiphilic dendrimers composed of 14 hydrophilic and bioactive saccharides (seven kinds) as dendrons and 7 hydrophobic peptides (di-and tetrapeptides) as arms with β-cyclodextrin (CD) as a core were facially designed and synthesized in several steps. Fourteen saccharides were first conjugated to the C-2 and C-3 positions of CD, forming glycodendrons. Subsequently, seven oligopeptide arms were introduced at the C-6 positions of a CD moiety by an acylhydrazone dynamic covale… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 52 publications
0
9
0
Order By: Relevance
“…Other exceptional Janus amphiphilic glycopeptide dendrimers for the biomimicry of glycans exhibited strong and specific recognitions with C-type mannose-specific lectin [ 144 ].…”
Section: Applications Of Amphiphilic Jdsmentioning
confidence: 99%
See 1 more Smart Citation
“…Other exceptional Janus amphiphilic glycopeptide dendrimers for the biomimicry of glycans exhibited strong and specific recognitions with C-type mannose-specific lectin [ 144 ].…”
Section: Applications Of Amphiphilic Jdsmentioning
confidence: 99%
“…They were self-assembled into different controllable nanostructures such as glycospheres, worm-like micelles, and fibers conditioned by the repeating unit fraction of saccharides and phenylalanine. These nanomaterials were successfully encapsulated with Nile red dye and fluorofenidone, an anti-inflammatory agent [ 144 ].…”
Section: Applications Of Amphiphilic Jdsmentioning
confidence: 99%
“…25−28 Biomedical applications of AKF-PD are limited by its poor solubility. 29 Previous studies have provided evidence that the solubility of AKF-PD is notably enhanced by β-CD. 30 Therefore, the application of macrocyclic molecules to improve drug aqueous solubility and bioavailability could be a suitable approach for AKF-PD.…”
Section: ■ Introductionmentioning
confidence: 99%
“…AKF-PD was approved for clinical trials by China Food and Drug Administration in 2016 (approval number: 2016L09979) and the phase I clinical trial was finished in 2019 . AKF-PD enters phase II clinical trials (ChiCTR2200065008) for hepatic fibrosis in China after its antifibrotic effects were demonstrated in various experimental models of liver, kidney, and lung fibrosis. , Furthermore, the drug has antioxidant, anti-apoptotic, and anti-inflammatory properties. Biomedical applications of AKF-PD are limited by its poor solubility . Previous studies have provided evidence that the solubility of AKF-PD is notably enhanced by β-CD .…”
Section: Introductionmentioning
confidence: 99%
“…CDMan and CDEG were synthesized following our previous work. 61 Synthesis of Rh-NH 2 . Rhodamine B (3.83 g, 8 mmol) and triethylenetetramine (6 mL, 40 mmol) were dissolved in EtOH (50 mL).…”
Section: ■ Introductionmentioning
confidence: 99%